Work

Safety, dose tolerance, pharmacokinetics and pharmacodynamics study of CPX-POM in patients with advanced solid tumors.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps2618

Authors: Scott James Weir, Robyn Wood, Tammy Ham, Rashida Challenger, Prabhu Ramamoorthy, Greg Reed, Michael Jay Baltezor, Roy A. Jensen, John Arthur Taylor, Shrikant Anant, Michael Dalton, Michael J McKenna, Valentina Zhukova-Harrill, William McCulloch, Howard A. Burris

Institutions: The University of Kansas Cancer Center, University of Kansas Medical Center, University of Kansas, UConn Health, Sarah Cannon

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891820713

Cites:

Cited by: 2

Related to: 10